Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 8514281)

1.

Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells.

Jørgensen N, Giwercman A, Müller J, Skakkebaek NE.

Histopathology. 1993 Apr;22(4):373-8.

PMID:
8514281
2.

Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells.

Jørgensen N, Müller J, Jaubert F, Clausen OP, Skakkebaek NE.

Histopathology. 1997 Feb;30(2):177-86.

PMID:
9190360
3.

Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.

Jørgensen N, Rajpert-De Meyts E, Graem N, Müller J, Giwercman A, Skakkebaek NE.

Lab Invest. 1995 Feb;72(2):223-31.

PMID:
7531795
4.
5.

Lack of RBM expression as a marker for carcinoma in situ of prepubertal dysgenetic testis.

Schreiber L, Lifschitz-Mercer B, Paz G, Yavetz H, Zadik Z, Kula K, Slowikowska-Hilczer J, Rey R, Elliott DJ, Maymon BB.

J Androl. 2003 Jan-Feb;24(1):78-84.

PMID:
12514087
6.

Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.

Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH.

J Pathol. 2004 Jul;203(3):849-57.

PMID:
15221945
7.

Monoclonal antibody 43-9F: an immunohistochemical marker of embryonal carcinoma of the testis.

Visfeldt J, Giwercman A, Skakkebaek NE.

APMIS. 1992 Jan;100(1):63-70.

PMID:
1536722
8.
9.

Double immunolabeling by the RBM and the PLAP markers for identifying intratubular (in situ) germ cell neoplasia of the testis.

Schreiber L, Lifschitz-Mercer B, Paz G, Yavetz H, Elliott DJ, Kula K, Slowikowska-Hilczer J, Maymon BB.

Int J Surg Pathol. 2003 Jan;11(1):17-20.

PMID:
12598912
10.

Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.

Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Machtens S, Werner M, Jonas U.

Cancer. 1996 Nov 1;78(9):1958-66.

PMID:
8909317
11.

Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.

Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, Leffers H, Rajpert-De Meyts E.

Clin Cancer Res. 2004 Dec 15;10(24):8521-30.

13.

Monoclonal antibody 43-9F as a sensitive immunohistochemical marker of carcinoma in situ of human testis.

Giwercman A, Lindenberg S, Kimber SJ, Andersson T, Müller J, Skakkebaek NE.

Cancer. 1990 Mar 1;65(5):1135-42.

PMID:
2406007
14.

Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis.

Giwercman A, Andrews PW, Jørgensen N, Müller J, Graem N, Skakkebaek NE.

Cancer. 1993 Aug 15;72(4):1308-14.

PMID:
8339218
15.

Carcinoma in situ of the testis: review of biological and clinical features.

Dieckmann KP, Skakkebaek NE.

Int J Cancer. 1999 Dec 10;83(6):815-22. Review.

PMID:
10597201
17.

Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.

Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, Hata J, von Keitz A, Looijenga LH, Millán JL, Oosterhuis JW, Pera M, Sawada M, Schmoll HJ, Skakkebaek NE, van Putten W, Stern P.

Int J Cancer. 1996 Jun 11;66(6):806-16.

PMID:
8647654
18.

Stem cell factor as a novel diagnostic marker for early malignant germ cells.

Stoop H, Honecker F, van de Geijn GJ, Gillis AJ, Cools MC, de Boer M, Bokemeyer C, Wolffenbuttel KP, Drop SL, de Krijger RR, Dennis N, Summersgill B, McIntyre A, Shipley J, Oosterhuis JW, Looijenga LH.

J Pathol. 2008 Sep;216(1):43-54. doi: 10.1002/path.2378.

PMID:
18566970
19.

[Expression of fetal antigens of gonocytes in the investigation of pathogenesis of germinal cell neoplasia].

Słowikowska-Hilczer J, Walczak R, Sosnowski M, Kula K.

Ginekol Pol. 1998 Jun;69(6):524-8. Polish.

PMID:
9695376
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk